Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Medicine|November 26, 2019
Efficacy and safety of anti-PD-1/PD-L1 agents vs chemotherapy in patients with gastric or gastroesophageal junction cancer: a systematic review and meta-analysisBi-Cheng Wang, Zhan-Jie Zhang, Chen Fu, et al.
Medicine|October 19, 2019
A meta-analysis of cisplatin-based concurrent chemoradiotherapy with or without cetuximab for locoregionally advanced nasopharyngeal carcinomaBi-Cheng Wang, Liang-Liang Shi, Chen Fu, et al.
Plos One|March 18, 2022
A Bayesian network meta-analysis of the primary definitive therapies for locoregionally advanced nasopharyngeal carcinoma: IC+CCRT, CCRT+AC, and CCRT aloneZhan-Jie Zhang, Liang-Liang Shi, Xiao-Hua Hong, et al.
Annals of Palliative Medicine|April 9, 2021
A tolerability and safety analysis of adding granulocyte-macrophage colony-stimulating factor to local radiotherapy in a case series of seven patients with thoracic cancerBi-Cheng Wang, Peng-Cheng Li, Bo-Hua Kuang, et al.
Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban|October 22, 2013
Optimization of parameters for preparation of docetaxel-loaded PLGA nanoparticles by nanoprecipitation methodWei Shi, Zhan-Jie Zhang, Yin Yuan, et al.
Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban|April 9, 2014
Synthesis and characterization of surface-modified Fe3O4 super-paramagnetic nanoparticlesZhan-Jie Zhang, Jia Ma, Shuang-Bing Xu, et al.
Current Medical Science|August 17, 2021
Long-term Therapeutic Outcome and Prognostic Factors of Patients with Nasopharyngeal Carcinoma Receiving Intensity-modulated Radiotherapy: An Analysis of 608 Patients from Low-endemic Regions of ChinaJing Huang, Zhi-Yong Yang, Bian Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2026
TQB2618 plus penpulimab, alone or in combination with chemotherapy, for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, two-cohort, phase 2 trialCheng Xu, Si-Yang Wang, Man Nie, et al.
Pageof 1